APOE E2 Determinant — The Protective Variant
This variant, together with rs429358, determines your APOE genotype. The rs7412 variant causes a missense change at position 176 of the APOE protein, substituting arginine with cysteine (p.Arg176Cys). This defines the APOE ε2 isoform.
The Mechanism
The E2 isoform has reduced affinity for the LDL receptor compared to E3, which paradoxically leads to lower LDL cholesterol in most carriers. The arginine-to-cysteine substitution alters the protein's lipid-binding properties, generally leading to more efficient cholesterol clearance from the bloodstream.
The Evidence
The E2 allele is generally protective for cardiovascular health. E2 carriers typically have lower LDL cholesterol and better lipid profiles overall.
However, the rare E2/E2 genotype (~1% of the population) can sometimes be associated with type III hyperlipoproteinemia11 A rare lipid disorder (OMIM #617347) where cholesterol-rich remnant particles accumulate, causing yellowish skin deposits and elevated cardiovascular risk, particularly when combined with other metabolic triggers such as obesity, diabetes, or hypothyroidism.
Practical Implications
The E2 allele is generally protective for cardiovascular health and Alzheimer's disease. E2 carriers typically have lower LDL cholesterol and better lipid profiles overall. However, the rare E2/E2 genotype (~1% of the population) can sometimes be associated with type III hyperlipoproteinemia, particularly when combined with other metabolic triggers such as obesity, diabetes, or hypothyroidism.
Interactions
The rs7412 and rs429358 variants together determine your complete APOE genotype (E2/E2, E2/E3, E3/E3, E3/E4, E2/E4, or E4/E4), which has implications for both cardiovascular health and Alzheimer's risk.